Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 48

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 48
---
, (ii) the information discussed in the section of this proxy statement/prospectus entitled “Risk Factors” and (iii) the information discussed under the section entitled “Risk Factors” in Aptorum’s 2024 Form 20 -Fand subsequent filings by Aptorum with the SEC. For more information, please see the section of this proxy statement/prospectus entitled “Where You Can Find More Information.” Neither Aptorum nor DiamiR is under any obligation, and each expressly disclaims any obligation, to update, alter or otherwise revise any forward -lookingstatements, whether written or oral, that may be made from time to time, whether as a result of new information, future events or otherwise, except as required by law. Persons reading this proxy statement/prospectus are cautioned not to place undue reliance on these forward -lookingstatements, which speak only as of the date hereof. 13 RISK FACTORS Before you vote, you should carefully consider the risks described below, and the risk factors described in the section entitled “Risk Factors” in Aptorum’s Annual Report on Form 20 -Ffor the year ended December 31, 2024, which is incorporated by reference into this proxy statement/prospectus. See the sections of this proxy statement/prospectus entitled “ Where You Can Find More Information” and “Cautionary Statement Regarding Forward -LookingStatements,” and the other information contained in this proxy statement/prospectus or in the documents of Aptorum incorporated by reference into this proxy statement/prospectus. In addition to those risks, new risks may emerge from time to time and it is not possible to predict all risk factors, nor can Aptorum or DiamiR assess the impact of all factors on the Merger and the Combined Company following the Merger or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in or implied by any forward -lookingstatements. Risks Related to the Merger If the Merger Agreement with DiamiR is not consummated, Aptorum’s share price could decline. The consummation of the Merger with DiamiR is subject to a number of closing conditions, including the completion of the Domestication, conversion of all outstanding convertible debt of ours and DiamiR’s, approval by our shareholders, completion of review by Nasdaq of Aptorum’s listing of additional securities application of the shares of common stock of the combined company to be issued in connection with the closing of the Merger, and other customary